Semaglutide: GLP-1 receptor agonist What semaglutide is: GLP-1 (glucagon-like peptide-1) receptor agonist FDA approved for weight loss (Wegovy) Also approved for diabetes (Ozempic) Weekly injection Well-established safety profile Most popular weight loss peptide How GLP-1 works: Mimics natural GLP-1 hormone Increases insulin secretion (glucose-dependent) Suppresses glucagon Slows gastric emptying (moderate) Reduces appetite via brain centers Increases satiety Semaglutide's benefits: 10-15% average body weight loss Improved glucose control Cardiovascular benefits Reduced food cravings Better metabolic health Established track record See our peptides for weight loss , best peptides for weight loss , semaglutide dosage calculator , semaglutide vs tirzepatide , and best peptide stack for weight loss

BPC-157 also modulates the nitric oxide (NO) system, helping regulate vascular tone and blood flow delivery to damaged tissue, and rapidly upregulates VEGFR2 gene expression in wound tissue making it particularly effective in the early phases of tissue repair
Variants influence whether someone is likely to respond well to GLP-1 RAs for weight loss
Research Applications BPC-157 is frequently used in scientific models to investigate: Soft tissue healing (muscles, tendons, ligaments) Gastrointestinal protection and mucosal regeneration Anti-inflammatory pathways Angiogenesis and vascular repair Neural tissue recovery Enhanced cellular signaling involved in wound healing Its versatility makes BPC-157 one of the most studied regenerative peptides, particularly in research involving connective tissue repair and inflammation reduction
The presence of DSIP-LI in several HPLC fractions from conditioned culture media indicates secretion of DSIP-LI from cultured pheochromocytoma cells
PMC+3Frontiers+3Diabetes Journals+3 People with type 2 diabetes (T2DM) have significantly increased risk of AD/dementia